SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041332
Filing Date
2023-08-10
Accepted
2023-08-10 16:12:41
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-20230630.htm   iXBRL 10-Q 2870811
2 EX-10.1 kzr-ex10_1.htm EX-10.1 88773
3 EX-31.1 kzr-ex31_1.htm EX-31.1 21611
4 EX-31.2 kzr-ex31_2.htm EX-31.2 21612
5 EX-32.1 kzr-ex32_1.htm EX-32.1 12992
6 GRAPHIC img39236108_0.jpg GRAPHIC 359160
  Complete submission text file 0000950170-23-041332.txt   11282441

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kzr-20230630_lab.xml EX-101.LAB 449804
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kzr-20230630.xsd EX-101.SCH 55799
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kzr-20230630_cal.xml EX-101.CAL 51853
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kzr-20230630_pre.xml EX-101.PRE 328553
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kzr-20230630_def.xml EX-101.DEF 171045
68 EXTRACTED XBRL INSTANCE DOCUMENT kzr-20230630_htm.xml XML 2215688
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 231159509
SIC: 2834 Pharmaceutical Preparations